Sign in
CompletedNo phase

taVNS to Reduce PTSD Symptoms in WTC Responders

Key facts

Who runs it
Northwell Health
Where
Manhasset, United StatesSee the site
Trial code
Status
Completed
People taking part
30 people enrolled
Started
31 Mar 2022
Ended
15 Feb 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • taVNS
Record updated
3 April 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • being a Queens WTCHP responder who agreed to be contacted to participate in research
  • having PTSD as per DSM criteria indicated by the GRDC
  • having elevated PTSD symptoms, indicated by a PCL-S93 score > 44 during an annual monitoring visit between 2018-2020
  • having a score of 33 or greater on the PCL-594 delivered during the initial phone screen to determine current symptomatology
  • meeting diagnostic indication of PTSD using a Clinician-Administered PTSD Scale (CAPS), which is a clinical interview assessment.95

Who cannot take part

  • previously implanted electrically active medical devices (e.g., cardiac pacemakers, automatic implantable cardioverter-defibrillators, VNS)
  • other major conditions, that in the judgment of the investigators/WTCHP medical staff, would make the participant unsuitable for inclusion or would interfere with the participant participating in or completing the study. these include:; current treatment with psychotropic medication, including tricyclics, antipsychotics, mood stabilizers, bupropion, barbiturates, stimulants, antiepileptics, opioid medications; current diagnosis or history of any clinically significant cardiac, endocrinologic, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic, neurologic, gastrointestinal, or immunologic; history of any of the following cardiovascular conditions: Moderate to severe congestive heart failure (New York Heart Association class III or IV); Recent (within past 6 months) cerebrovascular accident, myocardial infarction, coronary stenting; Uncontrolled hypertension as defined by a confirmed systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg; history of or active seizure disorder; history of recurrent vasovagal syncope episodes; diagnosis of cancer (other than non-invasive skin cancer or carcinoma in-situ of the cervix) within the 5 years prior to study entry; history of concurrent illness that requires hospitalization within 30 days prior to study entry; have hypertension/hypotension uncontrolled by medication; participation in another investigational trial during the 30 days prior to study entry or during this project
  • active disease involving the auricle or ear canal (e.g., otitis media, tinnitus, infection, perforated tympanic membrane, vestibular and/or balance, excessive cerumen production, skin irritation), unwilling to remove a piercing (e.g., daith or tragus), or use a device (e.g., hearing aid, cochlear implant) that would preclude daily use of the earpiece
  • history of unilateral or bilateral vagotomy
  • being physically/mentally unable to consent and participate
  • inability to speak, read, or write in English,
  • exhibiting any current psychotic or manic symptoms, active substance dependence, or current suicidal or homicidal intent/plan, as per the standard MINI neuropsychological assessment.96
  • Current pregnancy (self-report)

Where in United States

  • Feinstein Institutes for Medical ResearchManhasset, United States

About the trial

What the trial wants to find out

This study seeks to conduct a randomized, double-blind pilot study, to determine whether the Transcutaneous Auricular Vagus Nerve Stimulation and study procedure are feasible and acceptable for use with World Trade Center responders with Post Traumatic Stress Disorder.

The 2 groups in the trial

  • taVNS TreatmentTreatment being tested

    n = 20

    Treatment: taVNS

  • Sham ComparatorSham treatment, for comparison

    n = 10

    Treatment: taVNS

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) to Reduce Post Traumatic Stress Disorder (PTSD) Symptoms in World Trade Center (WTC) Responders
Publications
Record updated
3 April 2024